Humana Inc. (HUM)
USD 258.48
(0.95%)
USD 258.48
(0.95%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 4.93 Billion USD | 1.83% |
| 2022 | 4.67 Billion USD | 4.19% |
| 2021 | 4.34 Billion USD | -20.01% |
| 2020 | 5.44 Billion USD | 30.0% |
| 2019 | 4.17 Billion USD | 51.7% |
| 2018 | 2.84 Billion USD | -40.47% |
| 2017 | 4.74 Billion USD | 115.19% |
| 2016 | 2.2 Billion USD | -28.0% |
| 2015 | 3.06 Billion USD | 9.0% |
| 2014 | 2.81 Billion USD | 13.03% |
| 2013 | 2.48 Billion USD | 5.65% |
| 2012 | 2.35 Billion USD | -7.25% |
| 2011 | 2.53 Billion USD | 26.11% |
| 2010 | 2.11 Billion USD | 8.66% |
| 2009 | 1.85 Billion USD | 52.66% |
| 2008 | 1.29 Billion USD | -17.7% |
| 2007 | 1.47 Billion USD | 61.87% |
| 2006 | 910.68 Million USD | 65.41% |
| 2005 | 550.57 Million USD | 3.17% |
| 2004 | 533.64 Million USD | 13.18% |
| 2003 | 488.86 Million USD | 42.59% |
| 2002 | 347.91 Million USD | -6.62% |
| 2001 | 369.91 Million USD | 35.67% |
| 2000 | 290 Million USD | 193.21% |
| 1999 | -247.44 Million USD | -184.59% |
| 1998 | 331 Million USD | -12.43% |
| 1997 | 128 Million USD | 225.86% |
| 1996 | 116 Million USD | -67.6% |
| 1995 | 81 Million USD | 16.61% |
| 1994 | 307 Million USD | -88.88% |
| 1993 | 54 Million USD | -23.3% |
| 1992 | 309 Million USD | -35.02% |
| 1991 | 353 Million USD | 3.16% |
| 1990 | 342.2 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | 1.01 Billion USD | -26.73% |
| 2024 Q1 | 1.39 Billion USD | 1443.64% |
| 2024 Q2 | -307 Million USD | -6.36% |
| 2023 FY | - USD | 1.83% |
| 2023 Q4 | -231 Million USD | -116.1% |
| 2023 Q3 | 1.43 Billion USD | -10.2% |
| 2023 Q2 | 1.59 Billion USD | -17.12% |
| 2023 Q1 | 1.92 Billion USD | 465.4% |
| 2022 Q2 | 1.42 Billion USD | -4.69% |
| 2022 Q3 | 1.38 Billion USD | -2.67% |
| 2022 FY | - USD | 4.19% |
| 2022 Q1 | 1.49 Billion USD | 576.02% |
| 2022 Q4 | 341 Million USD | -75.4% |
| 2021 Q3 | 1.92 Billion USD | 88.24% |
| 2021 FY | - USD | -20.01% |
| 2021 Q2 | 1.02 Billion USD | -21.36% |
| 2021 Q1 | 1.29 Billion USD | 689.55% |
| 2021 Q4 | 221 Million USD | -88.49% |
| 2020 Q2 | 2.83 Billion USD | 205.05% |
| 2020 Q3 | 2.02 Billion USD | -28.59% |
| 2020 Q4 | -220 Million USD | -110.86% |
| 2020 FY | - USD | 30.0% |
| 2020 Q1 | 930 Million USD | 17.87% |
| 2019 Q4 | 789 Million USD | -28.92% |
| 2019 Q3 | 1.11 Billion USD | -22.97% |
| 2019 Q2 | 1.44 Billion USD | 52.16% |
| 2019 Q1 | 947 Million USD | 50.08% |
| 2019 FY | - USD | 51.7% |
| 2018 Q1 | 899 Million USD | 29.54% |
| 2018 FY | - USD | -40.47% |
| 2018 Q2 | 202 Million USD | -77.53% |
| 2018 Q3 | 1.09 Billion USD | 441.58% |
| 2018 Q4 | 631 Million USD | -42.32% |
| 2017 Q2 | 1.21 Billion USD | -34.32% |
| 2017 FY | - USD | 115.19% |
| 2017 Q4 | 694 Million USD | -29.04% |
| 2017 Q3 | 978 Million USD | -19.77% |
| 2017 Q1 | 1.85 Billion USD | 678.19% |
| 2016 Q4 | -321 Million USD | -130.11% |
| 2016 Q2 | 799 Million USD | 20.69% |
| 2016 FY | - USD | -28.0% |
| 2016 Q1 | 662 Million USD | 63.86% |
| 2016 Q3 | 1.06 Billion USD | 33.42% |
| 2015 Q4 | 404 Million USD | -49.63% |
| 2015 Q2 | 954 Million USD | 5.53% |
| 2015 Q3 | 802 Million USD | -15.93% |
| 2015 FY | - USD | 9.0% |
| 2015 Q1 | 904 Million USD | 82.63% |
| 2014 Q3 | 701 Million USD | -10.93% |
| 2014 FY | - USD | 13.03% |
| 2014 Q4 | 495 Million USD | -29.39% |
| 2014 Q2 | 787 Million USD | -4.95% |
| 2014 Q1 | 828 Million USD | 728.0% |
| 2013 Q4 | 100 Million USD | -86.24% |
| 2013 FY | - USD | 5.65% |
| 2013 Q3 | 727 Million USD | -8.32% |
| 2013 Q2 | 793 Million USD | -8.54% |
| 2013 Q1 | 867 Million USD | 111.98% |
| 2012 FY | - USD | -7.25% |
| 2012 Q4 | 409 Million USD | -45.68% |
| 2012 Q3 | 753 Million USD | 16.56% |
| 2012 Q2 | 646 Million USD | 38.03% |
| 2012 Q1 | 468 Million USD | 19.75% |
| 2011 FY | - USD | 26.11% |
| 2011 Q4 | 390.81 Million USD | -49.42% |
| 2011 Q3 | 772.64 Million USD | -3.56% |
| 2011 Q2 | 801.13 Million USD | 39.88% |
| 2011 Q1 | 572.71 Million USD | 137.84% |
| 2010 Q1 | 539.93 Million USD | 15.27% |
| 2010 Q2 | 668.62 Million USD | 23.83% |
| 2010 FY | - USD | 8.66% |
| 2010 Q3 | 760.68 Million USD | 13.77% |
| 2010 Q4 | 240.79 Million USD | -68.34% |
| 2009 Q2 | 500.42 Million USD | 42.26% |
| 2009 Q3 | 531.43 Million USD | 6.2% |
| 2009 Q4 | 468.39 Million USD | -11.86% |
| 2009 FY | - USD | 52.66% |
| 2009 Q1 | 351.77 Million USD | 9.64% |
| 2008 Q3 | 338.98 Million USD | -10.43% |
| 2008 Q4 | 320.85 Million USD | -5.35% |
| 2008 Q1 | 174.88 Million USD | -57.05% |
| 2008 FY | - USD | -17.7% |
| 2008 Q2 | 378.47 Million USD | 116.41% |
| 2007 Q3 | 520.75 Million USD | 32.22% |
| 2007 Q2 | 393.85 Million USD | 158.63% |
| 2007 Q4 | 407.22 Million USD | -21.8% |
| 2007 Q1 | 152.28 Million USD | -45.73% |
| 2007 FY | - USD | 61.87% |
| 2006 FY | - USD | 65.41% |
| 2006 Q4 | 280.6 Million USD | -2.25% |
| 2006 Q3 | 287.05 Million USD | 62.25% |
| 2006 Q2 | 176.91 Million USD | 6.5% |
| 2006 Q1 | 166.11 Million USD | 24.95% |
| 2005 Q2 | 156.61 Million USD | 7.32% |
| 2005 Q3 | 100.79 Million USD | -35.64% |
| 2005 Q4 | 132.94 Million USD | 31.89% |
| 2005 FY | - USD | 3.17% |
| 2005 Q1 | 145.92 Million USD | 51.49% |
| 2004 FY | - USD | 13.18% |
| 2004 Q3 | 158.71 Million USD | 6.15% |
| 2004 Q4 | 96.32 Million USD | -39.31% |
| 2004 Q1 | 129.08 Million USD | 2.24% |
| 2004 Q2 | 149.51 Million USD | 15.83% |
| 2003 Q4 | 131.15 Million USD | 4.76% |
| 2003 Q2 | 71.83 Million USD | 44.07% |
| 2003 Q3 | 125.26 Million USD | -9.14% |
| 2003 FY | - USD | 42.59% |
| 2003 Q1 | 82.47 Million USD | 232.78% |
| 2002 Q2 | 101.31 Million USD | -1.66% |
| 2002 Q4 | 32.03 Million USD | -74.26% |
| 2002 FY | - USD | -6.62% |
| 2002 Q1 | 102.97 Million USD | -7.96% |
| 2002 Q3 | 111.58 Million USD | 10.87% |
| 2001 Q4 | 102.91 Million USD | 21.3% |
| 2001 FY | - USD | 35.67% |
| 2001 Q1 | 49 Million USD | 2826.84% |
| 2001 Q2 | 85 Million USD | 1.84% |
| 2001 Q3 | 94 Million USD | -95.89% |
| 2000 Q3 | 36 Million USD | 3613.11% |
| 2000 Q4 | 79 Million USD | -96.82% |
| 2000 Q1 | 42 Million USD | 133.42% |
| 2000 FY | - USD | 193.21% |
| 2000 Q2 | 31 Million USD | -97.37% |
| 1999 FY | - USD | -184.59% |
| 1999 Q4 | - USD | -413.11% |
| 1999 Q2 | - USD | 1.21% |
| 1999 Q1 | - USD | 135.47% |
| 1999 Q3 | - USD | 2.03% |
| 1998 Q3 | - USD | -2.09% |
| 1998 Q4 | - USD | -392.3% |
| 1998 Q2 | - USD | 2.13% |
| 1998 Q1 | - USD | 145.69% |
| 1998 FY | - USD | -12.43% |
| 1997 Q2 | 26 Million USD | 0.57% |
| 1997 Q1 | 27 Million USD | 138.23% |
| 1997 FY | - USD | 225.86% |
| 1997 Q4 | 316 Million USD | -363.98% |
| 1997 Q3 | 29 Million USD | 7.2% |
| 1996 Q4 | 43 Million USD | -367.27% |
| 1996 Q3 | 27 Million USD | 18.25% |
| 1996 Q1 | 30 Million USD | 155.88% |
| 1996 Q2 | 27 Million USD | -6.21% |
| 1996 FY | - USD | -67.6% |
| 1995 Q4 | 317 Million USD | -356.02% |
| 1995 FY | - USD | 16.61% |
| 1995 Q2 | 17 Million USD | 2.47% |
| 1995 Q1 | 17 Million USD | 145.18% |
| 1995 Q3 | 18 Million USD | 2.62% |
| 1994 Q3 | 14 Million USD | 7.43% |
| 1994 Q2 | 40 Million USD | -1.03% |
| 1994 Q1 | 13 Million USD | 11.35% |
| 1994 FY | - USD | -88.88% |
| 1994 Q4 | 269 Million USD | -350.36% |
| 1993 FY | - USD | -23.3% |
| 1993 Q2 | 14 Million USD | -0.87% |
| 1993 Q3 | 13 Million USD | 0.73% |
| 1993 Q4 | 13 Million USD | 0.87% |
| 1993 Q1 | 14 Million USD | -23.39% |
| 1992 FY | - USD | -35.02% |
| 1992 Q2 | 92 Million USD | 0.32% |
| 1992 Q3 | 40 Million USD | -162.92% |
| 1992 Q1 | 88 Million USD | 3.98% |
| 1992 Q4 | 75 Million USD | 192.61% |
| 1991 Q1 | 88.8 Million USD | -92.91% |
| 1991 FY | - USD | 22.77% |
| 1991 Q4 | 89 Million USD | 1574.94% |
| 1991 Q2 | 88.8 Million USD | 0.0% |
| 1991 Q3 | 88.6 Million USD | -0.23% |
| 1990 Q2 | 87.9 Million USD | 6.81% |
| 1990 Q4 | 84 Million USD | 5.56% |
| 1990 FY | - USD | 0.0% |
| 1990 Q1 | 86.7 Million USD | 0.0% |
| 1990 Q3 | 79.8 Million USD | 0.19% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Cigna Corporation | 9.98 Billion USD | 50.636% |
| Centene Corporation | 5.61 Billion USD | 12.215% |
| CVS Health Corporation | 18.17 Billion USD | 72.879% |
| Elevance Health Inc. | 10.49 Billion USD | 53.003% |
| Molina Healthcare, Inc. | 1.74 Billion USD | -182.683% |
| Oscar Health, Inc. | -212 Million USD | 2425.439% |
| UnitedHealth Group Incorporated | 36.33 Billion USD | 86.43% |